These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 15056456
1. Neuronal COX-2 expression and phosphorylation of pRb precede p38 MAPK activation and neurofibrillary changes in AD temporal cortex. Hoozemans JJ, Veerhuis R, Rozemuller AJ, Arendt T, Eikelenboom P. Neurobiol Dis; 2004 Apr; 15(3):492-9. PubMed ID: 15056456 [Abstract] [Full Text] [Related]
2. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies. Ferrer I, Blanco R, Carmona M, Puig B. J Neural Transm (Vienna); 2001 Apr; 108(12):1397-415. PubMed ID: 11810404 [Abstract] [Full Text] [Related]
3. Ceramide is involved in r(+)-methanandamide-induced cyclooxygenase-2 expression in human neuroglioma cells. Ramer R, Weinzierl U, Schwind B, Brune K, Hinz B. Mol Pharmacol; 2003 Nov; 64(5):1189-98. PubMed ID: 14573769 [Abstract] [Full Text] [Related]
4. The unfolded protein response affects neuronal cell cycle protein expression: implications for Alzheimer's disease pathogenesis. Hoozemans JJ, Stieler J, van Haastert ES, Veerhuis R, Rozemuller AJ, Baas F, Eikelenboom P, Arendt T, Scheper W. Exp Gerontol; 2006 Apr; 41(4):380-6. PubMed ID: 16564150 [Abstract] [Full Text] [Related]
5. Maximal COX-2 and ppRb expression in neurons occurs during early Braak stages prior to the maximal activation of astrocytes and microglia in Alzheimer's disease. Hoozemans JJ, van Haastert ES, Veerhuis R, Arendt T, Scheper W, Eikelenboom P, Rozemuller AJ. J Neuroinflammation; 2005 Nov 21; 2():27. PubMed ID: 16300681 [Abstract] [Full Text] [Related]
6. p38 MAP kinase mediates endotoxin-induced expression of cyclooxygenase-2 in enterocytes. Grishin A, Wang J, Hackam D, Qureshi F, Upperman J, Zamora R, Ford HR. Surgery; 2004 Aug 21; 136(2):329-35. PubMed ID: 15300199 [Abstract] [Full Text] [Related]
7. Expression of stress-activated kinases c-Jun N-terminal kinase (SAPK/JNK-P) and p38 kinase (p38-P), and tau hyperphosphorylation in neurites surrounding betaA plaques in APP Tg2576 mice. Puig B, Gómez-Isla T, Ribé E, Cuadrado M, Torrejón-Escribano B, Dalfó E, Ferrer I. Neuropathol Appl Neurobiol; 2004 Oct 21; 30(5):491-502. PubMed ID: 15488025 [Abstract] [Full Text] [Related]
8. The expression of calcium/calmodulin-dependent protein kinase II-alpha in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathology. Wang YJ, Chen GH, Hu XY, Lu YP, Zhou JN, Liu RY. Brain Res; 2005 Jan 07; 1031(1):101-8. PubMed ID: 15621017 [Abstract] [Full Text] [Related]
9. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex. van de Nes JA, Nafe R, Schlote W. Brain Res; 2008 Jun 05; 1213():152-65. PubMed ID: 18455153 [Abstract] [Full Text] [Related]
10. Aspirin-mediated COX-2 transcript stabilization via sustained p38 activation in human intestinal myofibroblasts. Mifflin RC, Saada JI, Di Mari JF, Valentich JD, Adegboyega PA, Powell DW. Mol Pharmacol; 2004 Feb 05; 65(2):470-8. PubMed ID: 14742690 [Abstract] [Full Text] [Related]
11. Altered subcellular location of phosphorylated Smads in Alzheimer's disease. Ueberham U, Ueberham E, Gruschka H, Arendt T. Eur J Neurosci; 2006 Oct 05; 24(8):2327-34. PubMed ID: 17074053 [Abstract] [Full Text] [Related]
12. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Gómez-Isla T, Hollister R, West H, Mui S, Growdon JH, Petersen RC, Parisi JE, Hyman BT. Ann Neurol; 1997 Jan 05; 41(1):17-24. PubMed ID: 9005861 [Abstract] [Full Text] [Related]
13. Altered expression of COX-2 in subdivisions of the hippocampus during aging and in Alzheimer's disease: the Hisayama Study. Fujimi K, Noda K, Sasaki K, Wakisaka Y, Tanizaki Y, Iida M, Kiyohara Y, Kanba S, Iwaki T. Dement Geriatr Cogn Disord; 2007 Jan 05; 23(6):423-31. PubMed ID: 17457030 [Abstract] [Full Text] [Related]
14. Activation of synovial cell p38 MAP kinase by macrophage migration inhibitory factor. Santos LL, Lacey D, Yang Y, Leech M, Morand EF. J Rheumatol; 2004 Jun 05; 31(6):1038-43. PubMed ID: 15170913 [Abstract] [Full Text] [Related]
15. AgC10, a mucin from Trypanosoma cruzi, destabilizes TNF and cyclooxygenase-2 mRNA by inhibiting mitogen-activated protein kinase p38. Alcaide P, Fresno M. Eur J Immunol; 2004 Jun 05; 34(6):1695-704. PubMed ID: 15162440 [Abstract] [Full Text] [Related]
16. The early induction of cyclooxygenase 2 associated with neurofibrillary degeneration in brains of patients with Fukuyama-type congenital muscular dystrophy. Oka A, Itoh M, Takashima S. Neuropediatrics; 1999 Feb 05; 30(1):34-7. PubMed ID: 10222459 [Abstract] [Full Text] [Related]
17. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells. Chen TH, Kao YC, Chen BC, Chen CH, Chan P, Lee HM. Eur J Pharmacol; 2006 Jul 17; 541(3):138-46. PubMed ID: 16765938 [Abstract] [Full Text] [Related]
18. ERK1/2 and p38 mitogen-activated protein kinase mediate iNOS-induced spinal neuron degeneration after acute traumatic spinal cord injury. Xu Z, Wang BR, Wang X, Kuang F, Duan XL, Jiao XY, Ju G. Life Sci; 2006 Oct 12; 79(20):1895-905. PubMed ID: 16978658 [Abstract] [Full Text] [Related]
19. Activated c-Jun is present in neurofibrillary tangles in Alzheimer's disease brains. Pearson AG, Byrne UT, MacGibbon GA, Faull RL, Dragunow M. Neurosci Lett; 2006 May 08; 398(3):246-50. PubMed ID: 16481106 [Abstract] [Full Text] [Related]
20. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism. Grau R, Iñiguez MA, Fresno M. Cancer Res; 2004 Aug 01; 64(15):5162-71. PubMed ID: 15289320 [Abstract] [Full Text] [Related] Page: [Next] [New Search]